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Summary 
Clinical and immunohistochemical studies were done for 3-39 d on mice after intracerebral in- 
oculation with the neurovirulent A/WSN/33  (H1N1; WSN) strain of influenza A virus, the 
nonneurovirulent A/Aichi/2/68  (H3N2; Aichi) strain, and two reassortant viruses between them. 
The virus strains with the WSN gene segment coding for neuraminidase induced meningoen- 
cephalitis in mice. The mice inoculated with the R96 strain, which has only the neuraminidase 
gene from the WSN strain, had mild symptoms and weak positive immunostaining to the anti- 
WSN antibody in meningeal regions. Both the WSN and R404BP  strains, which contain the 
WSN  gene segments coding for neuraminidase and matrix protein,  were dearly neurovirulent 
both clinically and pathologically. On day 3 after inoculation with either of these two strains, 
WSN antigen was detected in meningeal and ependymal areas, neurons of circumventricular 
regions, the cerebral and cerebellar cortices, the substantia nigra zona compacta, and the ventral 
tegmental area. On day 7, meningeal reactions and neuronal  staining were still seen, and ad- 
vanced accumulation of the viral antigen was evident in the substantia nigra zona compacta and 
hippocampus.  Double immunostaining demonstrated that the WSN antigen was only seen in 
neurons and not in microglia or reactive  astrocytes. Immunostaining for the lectin maackia amurensis 
agglutinin, which recognizes the Neu5Ac ot2,3 Gal sequence, which serves as a binding site 
for influenza A virus on target cell membranes,  showed that positive staining was localized in 
the ventral substantia nigra and hippocampus. These results suggest that neurovirulent influenza 
A viruses could be one of the causative agents  for postencephalitic  parkinsonism. 
A 
ute,  often transitory Parkinsonism  has been reported 
during viral encephalitis. The causative viruses include 
Japanese encephalitis  B (1, 2), coxsackie  B2 (3), Western equine 
encephalitis (4), tick-borne encephalitis, and influenza A (5) 
viruses. Antigens of the influenza A virus have been detected 
in the brains of people with postencephalitic parkinsonism 
(6). Furthermore, the influenza A virus has been suspected 
as the causative agent of encephalitis lethargica, in which there 
is chronic progressive parkinsonism,  because of the concur- 
rence of that condition with the 1918-1928 influenza pan- 
demic (7-9). An increased risk of developing idiopathic Par- 
kinson's  disease in individuals  born during that influenza 
pandemic  has also been reported (10). However,  two neu- 
ropathological  reports,  one by Miyoshi et al.  (11) and the 
other by Reinacher et al. (12), studying the A/NWS/33 strain 
of influenza A virus in mouse brains did not show any damage 
to the substantia nigra such as that which occurs in parkin- 
sonism. 
The human influenza A viruses expressing neurovirulence 
in mice are the early H1N1 strains A/NWS/33 (NWS) and 
A/WSN/33  (WSN). NWS and WSN strains have been main- 
tained in many laboratories and have retained their unique 
pathogenic properties  (13). Neurovirulence has  also been 
reported  for  the  reassortant  strains  between  WSN  and 
A/Aichi/2/68 (14, 15). Infection of mice with these viruses 
was induced by intracerebral  inoculation that caused a meningo- 
encephalitic condition (12). 
The present studies were performed to evaluate the clin- 
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A  virus infection in mice after intracerebral injection. We 
used four different strains of influenza A virus and found clear 
involvement of neurons of the substantia nigra,  as well as 
of neurons in other circumventricular nuclei. 
Materials  and Methods 
Cell  Cultures  and  Virus  Strains.  Madin-Darby canine kidney 
(MDCK)  1  cells were propagated and maifitained as described pre- 
viously (14). Virus strains used in this study and their gene deriva- 
tions are presented in Table I. The A/WSN/33 (HIN1;WSN) and 
A/Aichi/2/68 (H3N2;Aichi) prototype strains and preparation of 
recombinants between them have been described in detail previ- 
ously (14). Viral infectivity was determined  by plaque assay in 
MDCK cells (15, 16). 
Mice and Viral lnoculation.  Specific  pathogen-free, 6 wk old male 
mice of the C3H/HeN inbred strain were purchased from Charles 
RAver Japan, Inc. (Tokyo, Japan). They were infected on the day 
after arrival and housed in cages that were placed  in a safety  cabinet. 
Each mouse received a direct intracerebral inoculation into left pa- 
rietal lobe with a double-tapered needle of  0.03 ml PBS containing 
5  x  103 pfu of the virus to be tested. The mice in one group re- 
ceived only PBS and the rest of the experimental groups received 
PBS containing one of the four strains used (Aichi, R96, R404BP, 
or WSN). The number of mice in each group was between 10 and 
30 (Table 2). 3, 7, 14, and 39 d after inoculation, they were evalu- 
ated clinically, and three to five mice of each group were killed 
and processed for immunohistochemistry  and virus plaque assays 
(Table 1). 
Clinical Evaluations.  Motor symptoms after virus inoculation, 
such as paresis, disequilibria, involuntary movements, or abrupt 
seizure-like fits, were observed daily and recorded for each mouse 
as described by Henle and Henle (17). The body weight  of each 
mouse was also measured before and after inoculation. Statistical 
analyses  were done using one-way  ANOVA followed  by the Scheffe's 
test. 
Immunohistockemistry.  Mice  were anesthetized  with sodium pen- 
tobarbital before all experiments. They were perfused through the 
heart with 0.01 M phosphate buffer, pH 7.4, and then with a fixa- 
tive consisting of 4% paraformaldehyde in 0.1 M PBS, pH 7.4. 
The brain was quickly removed and fixed for an additional 48 h 
at 4~  It was then transferred to 15% sucrose in 0.1 M PBS, and 
serially cut  at  20  /zm  on  a freezing  microtome  for immuno- 
histochemistry. Sections were rinsed three times with PBS con- 
taining 0.3% Triton X-100 (PBST) and then treated for 48 h in 
the cold with either anti-WSN antibody (rabbit polyclonal, 1:10,000) 
or anti-HK antibody (rabbit polyclonal, 1:10,000). The antibodies 
were prepared and well characterized by Ueda and Sugiura (18). 
After treatment with the primary antibody, the sections  were treated 
for 2 h at room temperature with a biotinylated secondary anti- 
body (Vector  Laboratories,  Budingame, CA) (goat anti-rabbit IgG, 
1:1,000), followed by incubation in the avidin-biotinylated horse- 
radish peroxidase complex (Vector). Washing between steps was 
__w 
1 Abbreviations used in this paper: anti-TH, antityrosine  hydroxylase;  CA, 
cornu ammonius; DAB, 3,Y-diaminobenzidine;  GFAP, glial  fibrillary  acidic 
protein; HPC, hippocampus; M, matrix  protein; MAA, maackia amurensis 
agglutinin; MDCK, Madin-Darby  canine kidney  (cells); NA, neuramini- 
dase; PBST, PBS containing 0.3% Triton X-100; SN, substantia nigra; 
SNA, sambucus nigra agglutinin; SNC, substantia nigra zona  compacta; 
SNR, substantia nigra zona reticulata; VTA, ventral tegmental area. 
done with PBST. Peroxidase  labeling was visualized by incubating 
with a solution containing 0.001% 3,Y-diaminobenzidine (DAB), 
0.6% nickel ammonium sulfate, 0.05% imidazole, and 0.0003% 
H202. When a dark purple product formed, the reaction was ter- 
minated. Sections  were washed, mounted on glass slides, dehydrated 
with graded alcohols, and coverslipped  with Entellan (Merck, Darm- 
stadt,  Germany). 
Double immunostaining was done using anti-WSN antibody and 
one of the following antibodies: antityrosine hydroxylase  (antityro- 
sine hydroxyhse [anti-TH]; Chemicon International, Inc., Temecula, 
CA) (mouse monoclonal,  1:1,000), antimacrophage (Boehringer 
Mannheim GmbH, Mannheim, Germany) (Mac-l, rat monoclonal, 
1:200), and antiglial fibrillary  acidic  protein (DAKO, Glostrup, Den- 
mark) (GFAP, rabbit polyclonal, 1:10,000). Sections were treated 
for 30 rain with 0.5% H202 solution in PBST after the DAB reac- 
tion of the first cycle.  The second cycle  was carried out in a manner 
similar to the tint, except that nickel ammonium sulfate  was omitted 
from the DAB solution, yielding a brown precipitate in the second 
cycle. Further details on the immunohistochemical procedures have 
been published previously (19). 
Digoxigenin-labeled  lectins of sambucus nigra agglutinin (SNA) 
and maackia amurensis agglutinin (MAA) were used to detect the 
carbohydrate moieties of glycoproteins serving as influenza A virus 
receptors. The MAA recognizes the sequence  Neu5Ac a2,3Gal and 
the SNA is specific  for the Neu5Ac a2,6Gal sequence. Slices were 
incubated in blocking solution (1% skim milk) at 4~  overnight 
to  avoid nonspecific binding.  The subsequent procedures were 
strictly according to the method recommended in the DIG Glycan 
Differential Kit from Boehringer Mannheim  (20). 
Virus Plaque Assay.  Freshly  frozen brain was ground in a motor- 
driven glass homogenizer and a suspension was prepared in 2 ml 
of PBS. The suspension was used to determine the content of in- 
fectious virus by plaque assay in MDCK cells (15, 16). 
Results 
Clinical  Evaluations 
Virus inoculation was achieved in all mice by intracerebral 
route without acute complications of seizure or respiratory 
arrest.  Brain  samples  obtained for immunohistochemistry 
(fixed)  and for plaque assay (frozen) in this study are listed 
in Table 1. Table 2 shows the body weight changes during 
the observation period. 
3 d  after inoculation,  the mice inoculated with PBS or 
Aichi/68 virus showed little difference in their behavior and 
were eager to eat. The R96 group showed a slight but in- 
significant decrease in motor activity and body weight com- 
pared to PBS mice. All mice in the R404BP and WSN groups 
lost body weight (Table 2) and showed decreased motor ac- 
tivity. All showed ruffled fur and frequent shivering. They 
ate poorly and were severely emaciated. Hyperirritability was 
also  seen when stimuli of noise, flashlight,  or touch were 
given. When suspended by their tails, almost all of the R404BP 
group and some of the WSN group showed marked tremu- 
lous  movements  and  clonic  convulsions  that  sometimes 
changed suddenly into tonic convulsions. When they were 
not being stimulated, the mice huddled in groups and kept 
still until the application of other noxious stimuli. Mice that 
showed convulsive movements developing into generalized 
clonic-tonic convulsions were prone to die within the next 
few days. 
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Genotype  Number  of samples (fixed/frozen) 
Virus 
strains  P1  P2  P3  HA  NP  NA  M  NS  3 d  7 d  14 d  28 d 
Aichi  H  H  H  H  H  H  H  H  3/2  3/2  3/2  3/2 
R96  H  H  H  H  H  W  H  H  3/2  3/2  3/2  3/2 
R~4BP  H  H  H  H  H  W  W  H  3/2  2/0*  NO  NO 
WSN  W  W  W  W  W  W  W  W  3/2  3/2  3/2  2/1 
Genes derived from WSN and Hong Kong (HK) are indicated by W and H, respectively  (14). 
P1, P2, P3, polymerase; HA, hemagglutinin; NP, nuclear protein; NA, neuraminidase; M, matrix protein, NS, nonstructural protein; NO, not 
obtained. 
* These samples were obtained on day 6. 
Within 7 d after inoculation, all 20 mice in the R404BP 
group and 10 out of 30 mice of the WSN group died with 
acute meningo-encephalitis. On day 6,  we killed the three 
surviving mice in the R404BP group because  they showed 
general prostration. The WSN group showed marked body 
weight loss on days 7 and 14 (Table 2) and the most severe 
clinical symptoms seen during the observation period on day 
7. The mice in the WSN group surviving beyond 7 d after 
inoculation showed gradual improvement in motor activity 
and body weight. 
During the early time period (3-14 d), there was a clear 
clinical distinction between mice in the R404BP and WSN 
groups, which showed meningo-encephalitis, and those in 
the PBS, Aichi/68, and R96 groups, which were either neu- 
rologicaUy  normal or very mildly affected.  Within 3 or 6 
wk after inoculation, however,  the difference in the clinical 
symptoms between the groups could not be observed in sur- 
viving mice. On day 39, the WSN group was neurologically 
normal. 
Immunohistochemical  Study with Anti-WSN  Antibody 
Of the brains taken for immunohistochemical study, only 
those from the WSN and R404BP groups showed clear evi- 
dence of  viral invasion. The brains from the R96 group showed 
only limited staining to anti-WSN antibody in the meninges, 
ependymal cells, and neurites. No pathological changes were 
seen in the PBS and Aichi/68 groups, except in the parietal 
cortex of the needle wounds. The neuropathological findings 
in the R404BP and WSN groups were predominantly in the 
meningeal, circumventricular, cortical, and nigral regions. 
Other parts of their brains showed only minor staining with 
marked differences from mouse to mouse. 
3  d  after Inoculation  in  the  WSN  and R404BP  Groups. 
Diffuse and granular staining were clearly seen in arachnoid, 
pia mater, and ependymal cells in all mice.  Reflecting the 
direct intracerebral route of the virus' entry, prominent in- 
volvement was mainly seen in the circurriventricular  regions, 
such  as  the  hippocampus  (HPC),  hypothalamus,  peria- 
queductal grey matter, and the regions surrounding the fourth 
ventricle.  Focal invasion of the WSN strain could be seen 
in  hippocampal  tissues  (Fig.  1 A).  Some neurons  in  the 
granular cell layer of the dentate gyms with fine neurites con- 
necting to the alveus were positively stained, as were a few 
neurons in the amygdala. Neurons in the anterior, lateral, 
and  ventromedian hypothalamic nucleus were  sometimes 
stained positively, and a few neurons in the locus ceruleus 
Table 2.  Mean ( +_SD) Body Weights in the Groups with PBS and Four Different Viruses 
Body weight (g) 
Groups  Before  3 d  7 d  14 d  39 d 
PBS (n)  22.6  +  0.6 (10)  24.7  _+  0.4 (10)  25.6  +  0.5 (7)  26.8  +  0.4 (4)  30.6  _+  1.5 (3) 
Aichi (n)  23.3  _+  1.3 (20)  25.8  _+  1.1 (20)  26.7  _+ 0.6  (15)  27.0  _+  0.9 (10)  30.2  _+  1.1 (5) 
R96 (n)  22.7  +  1.2 (20)  24.9  _+  1.1 (20)  26.3  _+  1.3 (15)  25.2  +  0.8 (10)  30.1  _+  1.9 (5) 
R404BP (n)  23.0  _+  1.4 (20)  21.8  _+  1.4 (20)* 
WSN (n)  23.0  +  1.3 (30)  21.5  +  1.6 (30)*  16.2  _+  1.0 (15)*  16.5  +  1.4 (8)*  27.1  _+  1.8 (5) 
n, number of mice. 
* Significantly  different  (P <0.01)  from the PBS group. 
2163  Takahashi  et al. Figure  1.  Immunohistochemistry with the anti-WSN antibody, counterstained with neutral red, in the HPC of mice from the R404BP group on 
day 3 (,4) and day 7 (B), and in the parietal cortex of mice in the WSN group on day 3 (C), and day 7 (D). (=4) Positively  stained neurons in the 
granular cell layer of the dentate gyrus with many neurites reaching the surface  ependymal  cell layer  are seen. However,  they show only focal immuno- 
staining. (B) Many neurons in the pyramidal  cell layer  are stained positively.  (C) Diffuse  and granular staining is seen  in the pia mater. In the parenchyma, 
a few neurons and many neurites are positive to the anti-WSN antibody. A few irregularly shaped, diffusely  labeled areas containing positively stained 
neurons are also seen in the cortex. (D) The immunostaining is almost the same as on day 3 (see C). Bar, 100 gm. 
located on the lateral wall of the fourth ventricle were some- 
times mildly stained. This neuronal staining varied from mouse 
to mouse,  showing  no constant  pattern. 
In the cerebral neocortex, positively stained neurons and 
neurites were scattered in the parieto=occipital regions, giving 
evidence of the route of viral invasion (Fig.  1 C).  A  few ir- 
regularly  immunopositive  areas  that  contained  positively 
stained neurons and surrounding neuropils were also seen (Fig. 
1 C).  In the cerebeUar cortex, a small number  of Purkinje 
cells and their dendrites were strongly stained. The other parts 
of cerebellum  showed  no  immunostaining. 
Constant  and reproducible positive staining was  seen in 
the neurons of the substantia nigra (SN) and ventral tegmental 
area (VTA) (Fig. 2, A  and B). Neurites in the substantia nigra 
zona reticulata  (SNR)  were also  stained  (Fig.  2  B). 
6 and 7 d after Inoculation.  During this period, meningeal 
involvement was still seen. The major pathology was, how- 
ever, in  the deep cortex and  white  matter  (Fig.  3). 
All of the cornu ammonius  1 (CA  1) and CA 2  showed 
diffuse immunolabeling of neuronal cells with numerous posi- 
tive branching  neurites  (Fig.  1 B).  In CA  3,  only a  small 
number of neurons were stained.  The dentate gyral lesions 
had subsided  and staining of the medial hypothalamic area 
was decreased compared to that seen on day 3.  Neurons in 
the central gray surrounding the aqueduct and the other cir- 
cumventricular regions showed the same staining pattern as 






































































































































































































































































































































































































































































































































































































































































































































































 A  ,  f  D  G 
Figure  3.  A  series  of  line 
drawings of sections through  the 
brain to illustrate the distribution 
of immunostaining  to anti-WSN 
antibody seen in a mouse of the 
R404BP group on day 6 after  in- 
oculaton. The large  dots  represent 
labeled neuronal perikarya. The 
small dots indicate  the labeling  of 
neurltes. Structures are named  ac- 
cording  to the atlas  by Paxinos  and 
Watson (21). 
on day 3. A few neurons in the locus ceruleus were also stained. 
In the neocortex, some areas showed mild neuronal staining 
throughout all the cortical layers (Fig. 2 D). In the cerebellum, 
less immunostaining was seen in Purkinje cells and their den- 
drites than on day 3. 
The neuronal involvement in the SN, especially the sub- 
stantia nigra  zona compacta (SNC),  was more  advanced. 
Marked staining were seen in the neurons of the SN and VTA. 
Many neurons in the VTA and almost all of the neurons in 
the SNC showed strong positive immunostaining (Fig.  2, 
C  and D).  The axons extending to the striatum were also 
stained. Neurites in the SNR, which may be dendrites from 
the SNC neurons, and some neurons in the interpeduncular 
nucleus were also clearly stained. Many cotton-like, irregu- 
larly round-shaped areas of staining were seen in the SN, 
probably reflecting a seepage of the WSN antigen through 
the neuropil (Fig. 2 D). Every sample obtained from the WSN 
and lk404BP groups had the same immunohistchemical pat- 
tern in the nigral region, and this was the most striking patho- 
logical change in the whole brain. 
2 wk and beyond after Inoculation.  No new pathological 
changes or lesions  were detected (data not shown) during 
these time periods. No viral antigen was observed in any brain 
areas of mice that survived up to 4 wk after inoculation. 
Double Immunostaining 
Double immunostaining with anti-WSN and anti-TH an- 
tibodies showed that a large number of TH-positive nigral 
cells had the WSN antigen. Some TH-positive neurons con- 
tained a WSN-positive nucleus (Fig. 4 C), suggesting early 
nuclear invasion of the virus. Double staining with anti-WSN 
and anti-Mac 1 antibodies (Fig. 4 D), or with anti-WSN and 
anti-GFAP antibodies (Fig. 4 E), revealed that the positive 
cells were neither astrocytes nor microglia. Morphologically, 
all the positive cells appeared  to be neurons. 
Lectin Immunostaining 
Staining with digoxigenin-MAA gave considerable labeling 
over the ventral surface of the SN (Fig.  4 A) and the hip- 
pocampal formation. In the cerebellum, the molecular layer 
and Purkinje cells were strongly stained (Fig. 4 B ). The other 
2166  Neurovirulence  of Influenza A Virus in Mice Figure 4.  Immunohistochemistry  with the antibody  to lectin in mice treated with PBS. (A) In a section through the optic chiasma, the ventral 
portion adjacent to the SN is diffuse  but densely stained for the lectin MAA, whereas the corresponding  region for the lectin SNA is not stained 
at all. (B) Staining for MAA shows diffuse  immunolabeling  in the molecular  cell  layer  and Purkinje  cells of the cerebellum. In contrast, staining for 
SNA shows no specific  immunolabeling.  Double immunostaining in mice from the WSN group on day 7 (C-E) Double immunostaining  with anti- 
WSN and anti-TH  antibodies (C) showed that a TH-positive  neuron  (brown)  in the SN contains a strongly  WSN-positive  nucleus and faintly  positive 
cytoplasm  (dark blue). Double  immunostaining with anti-WSN and anti-Mac-1 antibodies  (/9), or with anti-WSN and anti-GFAP  antibodies  (E), showed 
that WSN-positive  structures (brown) were not stained with either the anti-GFAP or anti-Mac-1 antibody  (dark blue). Bar in A and B, 100 #m, bar 
in C-E,  t0 Izm. 
areas of the cerebellum were not stained. In contrast, staining 
with digoxigenin-SNA did not give any positive reaction (Fig. 
4,  A  and B). 
Virus  Plaque Assay 
Virus replication was assessed by measuring the brain virus 
titer on day 14 in groups with surviving mice. Because of 
the inhibitory effect of brain suspensions, the minimal virus 
titer detectable was 20 pfu per brain.  Virus content in the 
brains of mice infected with Aichi or K96 viruses could not 
be detected by this method. In contrast, the brains infected 
with WSN virus had a titer of 1.2  x  104 pfu/ml. This in- 
dicated that  the WSN  strain showed an adaptation to the 
mouse brain at a period when the neurological signs had largely 
subsided. 
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Discussion 
We used four different recombinants between the neuroviru- 
lent  WSN  and  the  nonneurovirulent Aichi/68  strains  of 
influenza A virus. Three genes of the WSN strain, NA, and 
nonstructural protein, appear to be responsible, to different 
degrees,  for the neurovirulence in mice (14,  15).  Since the 
R404BP strain was equivalent in neurovirulence to the WSN 
strain, NS seems to be less significant for neurovirutence than 
NA  and  M  (22).  The  mild  clinical  symptoms  and  rapid 
recovery of the R96 strain suggest that M of the WSN virus 
may be responsible for efficient virus multiplication in the 
mouse brain. Our clinical and pathological findings indicate 
that NA of the WSN virus plays a dominant role for viral 
infection. Furthermore, the results of the virus plaque assays 
suggest that only WSN could adapt and replicate in the mouse brain. All of these results are consistent with previous reports 
(14, 15). 
The major finding in this study is that the targets of neu- 
rovirulent influenza A virus are the SN, VTA in the brain- 
stem and the HPC. The WSN antigens were distributed not 
only in the neurons, but also in surrounding areas, suggesting 
viral seepage from the neurons. The definite and progressive 
involvement of the SN  and HPC,  especially of the SNC, 
showed a selective and reproducible invasion of influenza A 
virus into parenchymal tissues of the mouse brain. Further- 
more,  there was  early  nuclear  invasion by  neurovirulent 
influenza A virus in some dopaminergic neurons in the SNC. 
Although our experiments  are limited to the acute phase, 
this result suggests that the SNC is vulnerable to attack by 
neurovirulent  influenza A virus. 
The hemagglutinin glycoproteins of influenza viruses bind 
to cell membrane receptor molecules that contain sialic acid, 
such as glycoproteins (23) and gangliosides (24). Every strain 
of influenza virus has its particular preference in sialic acid- 
binding  properties.  Human  influenza  virus  A/PK/8/34 
(H1N1), which has the same serotype as the WSN strain, 
recognizes Neu5Ac c~2, 3Gal more specifically than it does 
Neu5Ac or2, 6Gal, whereas A/Aichi/68 has the reverse pat- 
tern (25). Lectin immunostaining showing positive reactions 
in the SN, HPC, and cerebellar cortex,  where intense im- 
munolabelings to WSN antigen were also observed, suggesting 
that the neurovirulence of WSN strain and its localization 
in mice may depend partly on the distribution of Neu5Ac 
or2, 3Gal as a virus receptor (26). There are probably other 
factors determining  whether influenza virus can attach to host 
cell membrane and fuse with it to penetrate the cytoplasm 
after incorporation by receptor-mediated  endocytosis  (27). One 
such factor may be cleavage of hemagglutinin by a certain 
kind of trypsin-like protease to transform it into the active 
subunit for fusion (28). Further study is necessary to clarify 
the significance of these factors in the neuronal involvement. 
Analysis of the nucleotide sequences of eight influenza A 
virus RNA segments indicates that all of the influenza viruses 
in mammalian hosts originate from the gene pool in the aquatic 
avian reservoir. There are periodic exdaanges  of  influenza virus 
genes or whole viruses between species, giving rise to pan- 
demics in humans (29, 30). In the 20th century, there have 
been four such pandemics (1918-1919, 1957-1958, 1968-1969, 
and 1977), caused by the emergence of new subtypes of the 
influenza A virus. The great pandemic of 1918-1919, caused 
by the serotype of  HIN1, caused  an estimated 20 million deaths 
(31). Encephalitis  lethargica was observed worldwide between 
1915 and 1928 and then declined, with only very occasional 
reports of encephalitis cases after 1930. However, its sequela, 
postencephalitic parkinsonism/amyotrophic lateral sclerosis 
(especially  parkinsonism), was observed during the next two 
to three decades. Because of the concurrence of the 1918 
influenza pandemic  and a pandemic of encephalitis lethar- 
gica beginning with flu-like episodes, the influenza virus has 
been thought by a number of investigators to be the cause 
of encephalitis  lethargica. Virus localization  in this study, using 
the same H1N1 serotype, suggests that the influenza A virus 
has a strong potency to cause postencephalitic parkinsonism 
in humans. 
Several authors have hypothesized that influenza A virus 
infection may be a cause of Parkinson's disease (32-37).  The 
fact that the WSN strain of influenza A virus has an affinity 
to the SN,  as reported here, supports  this hypothesis. Via 
the natural route of infection, the blood-brain barrier should 
prevent virus invasion of the brain via blood vessels from the 
infected lung. Furthermore, it would be difficult for influenza 
A virus-infected cells to survive complement-mediated cell 
damage in blood circulation since virus-infected cells are reac- 
tive to homologous complement. Therefore, a possible route 
of infection to the brain may  be via the olfactory nerve system 
and this possibility is one of the most important questions 
to be answered. In the present experiment, we could not ob- 
tain chronic infection in the mouse brain. There remains the 
possibility of establishing new models showing chronic and 
persistent influenza A virus infection in the brain, which could 
help to clarify the relationship between postencephalitic par- 
kinsonism  and Parkinson's disease. 
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